The BioMarin Pharmaceutical Inc. acquisition of Amicus Therapeutics, Inc. will likely be beneficial and accretive for both ...

Scientists at Johns Hopkins Medicine say results of a new National Institutes of Health-funded study are advancing efforts to ...

PALI-2108 is the first and only PDE4 inhibitor in development targetingthe terminal ileum and colon for treatment of ulcerative colitis (UC) and fibrostenotic Crohn’s disease (FSCD) to address ...

Gilead Sciences, Inc. (NASDAQ:GILD) is one of the best affordable healthcare stocks to buy now. Gilead Sciences, Inc. (NASDAQ ...

Scientists at Johns Hopkins Medicine say results of a new study are advancing efforts to exploit a new target for Alzheimer's ...

Harvard Medical School researchers have uncovered crucial insights into how an emerging class of antiviral drugs works.

Mini-brains' grown in the lab allow scientists to study brain wiring without interfering with brains in living people, and ...

In 2025, we debunked several myths that have become popular in contemporary food culture, ranging from the common social ...

Ultragenyx Pharmaceutical Inc. (NASDAQ: RARE) today announced that it has completed the rolling submission of its Biologics License Application (BLA) to the U.S. Food and Drug Administration (FDA), ...

Experiments conducted in genetically engineered mice reinforce that CSE protein (ordinarily known for producing hydrogen ...

secrets to healthier living: transform your home into your own retreat centre for a quick detox, or enjoy eco-friendly ...

A new analysis of blood samples from patients with posttraumatic stress disorder reveals that the condition may be driven by ...